Better Access Key To Higher Survival For African-Americans With Colon Cancer
NCI Grant Supports Jefferson Trial To Study Test To Diagnose Colorectal Cancer Spread
Lung Cancer Survivors Claim Good QOL, Despite Challenges
“Acceptable” Images Found In Chest Scans Using Half Dose
More Radiation Increases Prostate Cancer Response
More Workers Quit Smoking When Health Messages Combined
Local Labs Not As Accurate As Central Testing For HER2
FDA Approves Aranesp For Chemo-Induced Anemia
Clinical Trials Approved By NCI CTEP During July
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
- Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)
- One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- As more people are surviving cancer, we must continue funding bold science
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis









